Aehr Test Systems (AEHR) Cash & Equivalents (2010 - 2026)

Aehr Test Systems' Cash & Equivalents history runs 17 years deep, the most recent figure standing at $116.4 million for Q2 2026.

• In Q2 2026, Cash & Equivalents rose 374.37% year-over-year to $116.4 million; the TTM figure through May 2026 stood at $116.4 million (up 374.37% YoY), while the FY2026 annual figure was $116.4 million, up 374.37% from the prior year.
• Cash & Equivalents for Q2 2026 stood at $116.4 million, up from $36.9 million in the prior quarter.
• The five-year high for Cash & Equivalents was $116.4 million in Q2 2026, with the low at $17.2 million in Q1 2023.
• The 5-year median for Cash & Equivalents is $32.1 million (2022), against an average of $38.6 million.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents soared 587.12% in 2022, then sank 50.1% in 2025.
• Aehr Test Systems' Cash & Equivalents stood at $18.9 million in 2022, then soared by 167.64% to $50.5 million in 2023, then tumbled by 36.22% to $32.2 million in 2024, then declined by 4.29% to $30.8 million in 2025, then surged by 277.36% to $116.4 million in 2026.
• Business Quant data shows AEHR's Cash & Equivalents at $116.4 million in Q2 2026, $36.9 million in Q1 2026, and $30.8 million in Q4 2025.